Identification of a Novel Mutation in a Family with Pseudohypoparathyroidism Type 1a

Detalhes bibliográficos
Autor(a) principal: Moutinho, A
Data de Publicação: 2018
Outros Autores: Carvalho, R, Ferreira-Reis, R, Tavares, S
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.23/1270
Resumo: INTRODUCTION: Pseudohypoparathyroidism type 1a is caused by GNAS mutations leading to target organ resistance to multiple hormones rather than parathyroid hormone, resulting not only in hypocalcemia, but also in Albright's hereditary osteodystrophy phenotype. MATERIALS AND METHODS: DNA sequencing of the GNAS gene identified a novel heterozygous mutation in peripheral blood leukocytes in the family presented in this case report. RESULTS: We present a case of a 25-year-old woman with pseudohypoparathyroidism type 1a admitted with seizures, whose family presents an autosomal dominant transmission of a novel heterozygous GNAS mutation (c.524_530+3del). CONCLUSION: Pseudohypoparathyroidism type 1a is mostly caused by inactivating GNAS mutations that have been gradually reported in the literature that lead to a typical and complex clinical phenotype and resistance to multiple hormones. The deletion caused by the mutation identified in the presented case has not been reported previously.
id RCAP_807b01ce1cbe73f75e055d160e02e98f
oai_identifier_str oai:repositorio.hospitaldebraga.pt:10400.23/1270
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Identification of a Novel Mutation in a Family with Pseudohypoparathyroidism Type 1aAnálise Mutacional de DNAPseudo-Hipoparatireoidismo/genéticaPredisposição Genética para DoençaINTRODUCTION: Pseudohypoparathyroidism type 1a is caused by GNAS mutations leading to target organ resistance to multiple hormones rather than parathyroid hormone, resulting not only in hypocalcemia, but also in Albright's hereditary osteodystrophy phenotype. MATERIALS AND METHODS: DNA sequencing of the GNAS gene identified a novel heterozygous mutation in peripheral blood leukocytes in the family presented in this case report. RESULTS: We present a case of a 25-year-old woman with pseudohypoparathyroidism type 1a admitted with seizures, whose family presents an autosomal dominant transmission of a novel heterozygous GNAS mutation (c.524_530+3del). CONCLUSION: Pseudohypoparathyroidism type 1a is mostly caused by inactivating GNAS mutations that have been gradually reported in the literature that lead to a typical and complex clinical phenotype and resistance to multiple hormones. The deletion caused by the mutation identified in the presented case has not been reported previously.Repositório Científico do Hospital de BragaMoutinho, ACarvalho, RFerreira-Reis, RTavares, S2018-07-06T11:26:30Z2018-01-01T00:00:00Z2018-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.23/1270engCase Rep Endocrinol. 2018 Jan 22;2018:7813591.10.1155/2018/7813591info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-21T09:03:10Zoai:repositorio.hospitaldebraga.pt:10400.23/1270Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:55:48.282714Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Identification of a Novel Mutation in a Family with Pseudohypoparathyroidism Type 1a
title Identification of a Novel Mutation in a Family with Pseudohypoparathyroidism Type 1a
spellingShingle Identification of a Novel Mutation in a Family with Pseudohypoparathyroidism Type 1a
Moutinho, A
Análise Mutacional de DNA
Pseudo-Hipoparatireoidismo/genética
Predisposição Genética para Doença
title_short Identification of a Novel Mutation in a Family with Pseudohypoparathyroidism Type 1a
title_full Identification of a Novel Mutation in a Family with Pseudohypoparathyroidism Type 1a
title_fullStr Identification of a Novel Mutation in a Family with Pseudohypoparathyroidism Type 1a
title_full_unstemmed Identification of a Novel Mutation in a Family with Pseudohypoparathyroidism Type 1a
title_sort Identification of a Novel Mutation in a Family with Pseudohypoparathyroidism Type 1a
author Moutinho, A
author_facet Moutinho, A
Carvalho, R
Ferreira-Reis, R
Tavares, S
author_role author
author2 Carvalho, R
Ferreira-Reis, R
Tavares, S
author2_role author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Hospital de Braga
dc.contributor.author.fl_str_mv Moutinho, A
Carvalho, R
Ferreira-Reis, R
Tavares, S
dc.subject.por.fl_str_mv Análise Mutacional de DNA
Pseudo-Hipoparatireoidismo/genética
Predisposição Genética para Doença
topic Análise Mutacional de DNA
Pseudo-Hipoparatireoidismo/genética
Predisposição Genética para Doença
description INTRODUCTION: Pseudohypoparathyroidism type 1a is caused by GNAS mutations leading to target organ resistance to multiple hormones rather than parathyroid hormone, resulting not only in hypocalcemia, but also in Albright's hereditary osteodystrophy phenotype. MATERIALS AND METHODS: DNA sequencing of the GNAS gene identified a novel heterozygous mutation in peripheral blood leukocytes in the family presented in this case report. RESULTS: We present a case of a 25-year-old woman with pseudohypoparathyroidism type 1a admitted with seizures, whose family presents an autosomal dominant transmission of a novel heterozygous GNAS mutation (c.524_530+3del). CONCLUSION: Pseudohypoparathyroidism type 1a is mostly caused by inactivating GNAS mutations that have been gradually reported in the literature that lead to a typical and complex clinical phenotype and resistance to multiple hormones. The deletion caused by the mutation identified in the presented case has not been reported previously.
publishDate 2018
dc.date.none.fl_str_mv 2018-07-06T11:26:30Z
2018-01-01T00:00:00Z
2018-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.23/1270
url http://hdl.handle.net/10400.23/1270
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Case Rep Endocrinol. 2018 Jan 22;2018:7813591.
10.1155/2018/7813591
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130426938228736